You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 22, December 9, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (92)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Cholesterol—Lowering Activity of Granulocyte-Macrophage Colony-Stimulating Factor

Stephen D. Nimer, MD; Richard E. Champlin, MD; David W. Golde, MD

JAMA. 1988;260(22):3297-3300.


Abstract

Human granulocyte-macrophage colony-stimulating factor (GM-CSF) is a glycoprotein hormone that stimulates the growth of hematopoietic progenitor cells and enhances the functional activity of mature myeloid effector cells. Granulocyte-macrophage colony-stimulating factor was administered to eight patients with severe aplastic anemia in an attempt to restore adequate hematopoiesis. Profound decreases in serum cholesterol concentrations were observed during GM-CSF therapy that were not dependent on changes in the patients' peripheral blood cell counts. Serum cholesterol levels decreased by an average of 37% during treatment, reaching levels of less than 4.40 mmol/L in all patients. Serum cholesterol concentrations returned to baseline in all patients after discontinuation of GM-CSF therapy. Treatment with GM-CSF prominently alters cholesterol homeostasis in vivo, although the mechanism of this effect is unknown. Our results suggest that GM-CSF may be potentially useful in the treatment of hypercholesterolemia and, possibly, in the prevention and treatment of atherosclerosis.

(JAMA 1988;260:3297-3300)



Author Affiliations

From the Department of Medicine, the Division of Hematology-Oncology, University of California at Los Angeles School of Medicine.


Footnotes

Reprint requests to the Division of Hematology-Oncology, University of California at Los Angeles School of Medicine, CHS Bldg, Room 42-121, Los Angeles, CA 90024-1678 (Dr Nimer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in Atherosclerosis
Gautier et al.
Circulation 2009;119:2367-2375.
ABSTRACT | FULL TEXT  

Aerobic capacity-dependent differences in cardiac gene expression
Bye et al.
Physiol. Genomics 2008;33:100-109.
ABSTRACT | FULL TEXT  

Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
Khovidhunkit et al.
J. Lipid Res. 2004;45:1169-1196.
ABSTRACT | FULL TEXT  

Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice
PLENZ et al.
FASEB J. 2003;17:1451-1457.
ABSTRACT | FULL TEXT  

Twenty-Six-Week Repeat-Dose Toxicity Study of a Recombinant Human Granulocyte Colony-Stimulating Factor Derivative (Nartograstim) in Cynomolgus Monkeys
Okasaki et al.
Toxicol Sci 2002;65:246-255.
ABSTRACT | FULL TEXT  

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease
van Royen et al.
Cardiovasc Res 2001;49:543-553.
ABSTRACT | FULL TEXT  

Granulocyte-Macrophage Colony–Stimulating Factor Prevents the Progression of Atherosclerosis via Changes in the Cellular and Extracellular Composition of Atherosclerotic Lesions in Watanabe Heritable Hyperlipidemic Rabbits
Shindo et al.
Circulation 1999;99:2150-2156.
ABSTRACT | FULL TEXT  

Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
Armitage
Blood 1998;92:4491-4508.
FULL TEXT  

Smooth Muscle Cells Express Granulocyte-Macrophage Colony-Stimulating Factor in the Undiseased and Atherosclerotic Human Coronary Artery
Plenz et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2489-2499.
ABSTRACT | FULL TEXT  

Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies
Kwong et al.
J. Clin. Endocrinol. Metab. 1997;82:1572-1581.
ABSTRACT | FULL TEXT  

Effects of CSF-1 on Cholesterol Accumulation and Efflux by Macrophages
Jessup et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:18-25.
ABSTRACT | FULL TEXT  

Insulin-like Growth Factor and Apolipoprotein B
Ostlund et al.
JAMA 1991;266:1937-1938.
ABSTRACT  

Clinical Pharmacology
Reidenberg
JAMA 1989;261:2831-2832.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.